Growing Medical Advancements
Medical advancements in the field of transdermal patch drug delivery system, for instance, TEPI patches and others, is anticipated to drive the market growth. The TEPI patch technology utilizes adhesives that are pressure sensitive and remains in contact with skin throughout the dosing period. The rate of drug release can be adjusted in accordance to the required pharmacokinetic profile coupled with adhesives that have high loading capacity owing to which wide range of medium can be used. Additionally, the manufacturing of these patches have easy processes, are environment friendly, and require no organic solvents, which is also anticipated to raise the demand for transdermal patch drug delivery system market.
Rapid Development in Product Features
Rapid developments in the features of transdermal patches, for instance, prolonged therapeutic effect, improved bio availability and ease of application among others, is anticipated to drive the market growth over the forecast period. Furthermore, transdermal patches have observed rapid demand for its utilization in cases where patients could not consume heavy oral doses, or drugs that get effected by gastro intestinal enzymes and for unconscious patients.
Restraints
Restrictions in Form, Shape and Size
The patches deliver drug dosage through skin which implies that the drug molecule should be small enough to penetrate through as the skin acts as the barrier to any environmental impurity that tries to enter the body. Owing to this the drug molecule that can be delivered through transdermal patch has limitation of size, weight which should be less than 500Da coupled with aqueous and lipid solubility. Additionally, these patches when applied on the skin causes irritation, erythema and local edema at times owing to the drug or adhesive used.
Competition from Oral Pharmaceuticals
Continuous medical advancements have resulted in the development of oral pharmaceuticals and medication facilities which have improved features and specifications in drug delivery system. Oral dosage process is accepted more than pushing injections amongst the patients, which might restraint the growth of the market. All of these factors are anticipated to act as a barrier to the growth of the transdermal patch drug delivery system market.
